Spembly Medical Limited Sustainability Profile
Spembly Medical Limited, a prominent player in the healthcare industry, is headquartered in Great Britain and operates extensively across Europe and beyond. Founded in 2010, the company has established itself as a leader in medical device innovation, focusing on advanced diagnostic and therapeutic solutions. Spembly Medical is renowned for its cutting-edge products, including state-of-the-art imaging systems and patient monitoring technologies, which are designed to enhance clinical outcomes and streamline healthcare delivery. The company’s commitment to quality and innovation has earned it a strong market position, with notable achievements in regulatory approvals and partnerships with leading healthcare providers. With a focus on improving patient care and operational efficiency, Spembly Medical Limited continues to set benchmarks in the medical technology sector, making significant strides in enhancing the future of healthcare.
DitchCarbon Score
How does Spembly Medical Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Spembly Medical Limited's score of 39 is higher than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Spembly Medical Limited, headquartered in Great Britain, currently does not report specific carbon emissions data for the most recent year, as indicated by the absence of emissions figures. The company is a current subsidiary of Integra LifeSciences Holdings Corporation, which may influence its climate commitments and reporting practices. As part of its corporate family, Spembly Medical Limited's climate initiatives and performance are likely aligned with those of Integra LifeSciences. However, specific reduction targets or achievements have not been disclosed for Spembly Medical Limited itself. The absence of documented reduction initiatives or commitments suggests that the company may still be in the early stages of developing its climate strategy. Given the lack of direct emissions data and reduction targets, it is essential for Spembly Medical Limited to establish clear climate commitments and measurable goals to enhance its sustainability profile and align with industry standards.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 13,902,000 | 00,000,000 | 0,000,000 |
| Scope 2 | 18,609,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | 000,000,000 | 000,000,000 |
How Carbon Intensive is Spembly Medical Limited's Industry?
How Carbon Intensive is Spembly Medical Limited's Location?
Spembly Medical Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Spembly Medical Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
